Wang F - Search Results

1

Hepatic effects of duloxetine-I: non-clinical and clinical trial data.

Wernicke J, Pangallo B, Wang F, Murray I, Henck JW, Knadler MP, D'Souza DN, Uetrecht JP. Wernicke J, et al. Among authors: wang f. Curr Drug Saf. 2008 May;3(2):132-42. doi: 10.2174/157488608784529189. Curr Drug Saf. 2008. PMID: 18690991 Review.

2

An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.

Wernicke J, Lledó A, Raskin J, Kajdasz DK, Wang F. Wernicke J, et al. Among authors: wang f. Drug Saf. 2007;30(5):437-55. doi: 10.2165/00002018-200730050-00007. Drug Saf. 2007. PMID: 17472422

3

An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.

Wernicke JF, Wang F, Pritchett YL, Smith TR, Raskin J, D'Souza DN, Iyengar S, Chappell AS. Wernicke JF, et al. Among authors: wang f. Pain Med. 2007 Sep;8(6):503-13. doi: 10.1111/j.1526-4637.2006.00258.x. Pain Med. 2007. PMID: 17716324 Clinical Trial.

4

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.

Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF. Raskin J, et al. Among authors: wang f. Pain Med. 2005 Sep-Oct;6(5):346-56. doi: 10.1111/j.1526-4637.2005.00061.x. Pain Med. 2005. PMID: 16266355 Clinical Trial.

5

Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.

Hall JA, Wang F, Oakes TM, Utterback BG, Crucitti A, Acharya N. Hall JA, et al. Among authors: wang f. Expert Opin Drug Saf. 2010 Jul;9(4):525-37. doi: 10.1517/14740338.2010.484418. Expert Opin Drug Saf. 2010. PMID: 20465525

6

Pain response profile of patients with fibromyalgia treated with duloxetine.

Bradley LA, Wohlreich MM, Wang F, Gaynor PJ, Robinson MJ, D'Souza DN, Mease PJ. Bradley LA, et al. Among authors: wang f. Clin J Pain. 2010 Jul-Aug;26(6):498-504. doi: 10.1097/AJP.0b013e3181dee80e. Clin J Pain. 2010. PMID: 20551724 Clinical Trial.

7

Effect of duloxetine in patients with fibromyalgia: tiredness subgroups.

Bradley LA, Bennett R, Russell IJ, Wohlreich MM, Chappell AS, Wang F, D'Souza DN, Moldofsky H. Bradley LA, et al. Among authors: wang f. Arthritis Res Ther. 2010;12(4):R141. doi: 10.1186/ar3081. Epub 2010 Jul 14. Arthritis Res Ther. 2010. PMID: 20630058 Free PMC article.

8

Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.

Raskin J, Wang F, Pritchett YL, Goldstein DJ. Raskin J, et al. Among authors: wang f. Pain Med. 2006 Sep-Oct;7(5):373-85. doi: 10.1111/j.1526-4637.2006.00207.x. Pain Med. 2006. PMID: 17014595 Clinical Trial.

9

The effect of duloxetine treatment on cognition in patients with fibromyalgia.

Mohs R, Mease P, Arnold LM, Wang F, Ahl J, Gaynor PJ, Wohlreich MM. Mohs R, et al. Among authors: wang f. Psychosom Med. 2012 Jul-Aug;74(6):628-34. doi: 10.1097/PSY.0b013e31825b9855. Epub 2012 Jun 28. Psychosom Med. 2012. PMID: 22753629 Clinical Trial.

10

Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies.

Brunton S, Wang F, Edwards SB, Crucitti AS, Ossanna MJ, Walker DJ, Robinson MJ. Brunton S, et al. Among authors: wang f. Drug Saf. 2010 May 1;33(5):393-407. doi: 10.2165/11319200-000000000-00000. Drug Saf. 2010. PMID: 20397739

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50,315 results

Search Page

Filters